Search Results - David C. Wheeler

Refine Results
  1. 1
    A comparison of spatial clustering and cluster detection techniques for childhood leukemia incidence in Ohio, 1996 – 2003

    A comparison of spatial clustering and cluster detection techniques for childhood leukemia incidence in Ohio, 1996 – 2003 by David C. Wheeler

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease

    The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease by James Tomlinson, David C. Wheeler

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?

    Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? by David C. Wheeler, Gavin J. Becker

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Fish consumption and prostate cancer risk: a review and meta-analysis

    Fish consumption and prostate cancer risk: a review and meta-analysis by Konrad Szymański, David C. Wheeler, Lorelei A. Mucci

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    New pharmacological strategies for protecting kidney function in type 2 diabetes

    New pharmacological strategies for protecting kidney function in type 2 diabetes by Marcel H.A. Muskiet, David C. Wheeler, Hiddo J.L. Heerspink

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Burden of impaired awareness of hypoglycemia in people with diabetes undergoing hemodialysis

    Burden of impaired awareness of hypoglycemia in people with diabetes undergoing hemodialysis by Hellena Hailu Habte‐Asres, Yutong Jiang, Miranda Rosenthal, David C. Wheeler

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Lipid peroxidation contributes to hydrogen peroxide induced cytotoxicity in renal epithelial cells

    Lipid peroxidation contributes to hydrogen peroxide induced cytotoxicity in renal epithelial cells by Alice M. Sheridan, Sean Fitzpatrick, Candice Wang, David C. Wheeler, Wilfred Lieberthal

    Published 1996
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Workplace support and breastfeeding duration: The mediating effect of breastfeeding intention and self‐efficacy

    Workplace support and breastfeeding duration: The mediating effect of breastfeeding intention and self‐efficacy by Jordyn T. Wallenborn, Robert A. Perera, David C. Wheeler, Juan Lü, Saba W. Masho

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit

    How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit by Lois G. Kim, Faye Cleary, David C. Wheeler, Ben Caplin, Dorothea Nitsch, Sally Hull

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury

    Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury by David C. Wheeler, Ravinder S. Chana, Nicholas Topley, Meryl M. Petersen, Malcolm Davies, John D. Williams

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    PPAR Agonists Protect Mesangial Cells from Interleukin 1β-Induced Intracellular Lipid Accumulation by Activating the ABCA1 Cholesterol Efflux Pathway

    PPAR Agonists Protect Mesangial Cells from Interleukin 1β-Induced Intracellular Lipid Accumulation by Activating the ABCA1 Cholesterol Efflux Pathway by Xiong Z. Ruan, John F. Moorhead, Ray Fernando, David C. Wheeler, Stephen H. Powis, Zac Varghese

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Does Folic Acid Decrease Plasma Homocysteine and Improve Endothelial Function in Patients With Predialysis Renal Failure?

    Does Folic Acid Decrease Plasma Homocysteine and Improve Endothelial Function in Patients With Predialysis Renal Failure? by Jeetendra Thambyrajah, Martin Landray, Fiona J McGlynn, Heather J. Jones, David C. Wheeler, Jonathan N. Townend

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

    A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease by J Thambyrajah, Martin Landray, Heather J. Jones, Fiona J McGlynn, David C. Wheeler, Jonathan N. Townend

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model

    Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model by Phil McEwan, V. Foos, Geraint Roberts, Robert L. Jenkins, Marc Evans, David C. Wheeler, Jieling Chen

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Mechanisms of Dysregulation of Low-Density Lipoprotein Receptor Expression in Vascular Smooth Muscle Cells by Inflammatory Cytokines

    Mechanisms of Dysregulation of Low-Density Lipoprotein Receptor Expression in Vascular Smooth Muscle Cells by Inflammatory Cytokines by Xiong Z. Ruan, John F. Moorhead, Jian L. Tao, Kun Liu, David C. Wheeler, Stephen H. Powis, Zac Varghese

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories

    Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories by Adeera Levin, Vlado Perkovic, David C. Wheeler, Stefan Hantel, Jyothis T. George, Maximilian von Eynatten, Audrey Koitka‐Weber, Christoph Wanner

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-γ–dependent mechanism

    EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-γ–dependent mechanism by Hang Li, Xiong Z. Ruan, Stephen H. Powis, R. Fernando, Wint Mon, David C. Wheeler, John F. Moorhead, Zac Varghese

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Synthesis of 1,25-Dihydroxyvitamin D3 by Human Endothelial Cells Is Regulated by Inflammatory Cytokines

    Synthesis of 1,25-Dihydroxyvitamin D3 by Human Endothelial Cells Is Regulated by Inflammatory Cytokines by Daniel Zehnder, Rosemary Bland, Ravinder S. Chana, David C. Wheeler, Alexander J. Howie, Mary C. Williams, Paul M. Stewart, Martin Hewison

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood Pressure

    Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood Pressure by Ben Caplin, Zhen Wang, Anna Slaviero, James Tomlinson, Laura Dowsett, Mathew Delahaye, Alan D. Salama, David C. Wheeler, James Leiper

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease

    Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease by Claire C. J. Dekkers, David C. Wheeler, C. David Sjöström, Bergur V. Stefánsson, Valerie A. Cain, Hiddo J.L. Heerspink

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: